...
首页> 外文期刊>European journal of gastroenterology and hepatology >Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients.
【24h】

Relationship between genotypes of hepatitis C virus and histopathological manifestations in chronic hepatitis C patients.

机译:慢性丙型肝炎患者的丙型肝炎病毒基因型与组织病理学表现之间的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The aim of this study was to assess the relationship between HCV genotype and histological liver injury. DESIGN: Prospective study on a cohort of patients with biopsy proven chronic hepatitis C. SETTING: University medical centre. PARTICIPANTS: Enrolled were 324 consecutive patients (male 197, median age 52 years, range 19-68; chronic hepatitis, 224; cirrhosis, 100). METHODS: HCV genotype was determined by the INNO LiPA assay and HCV RNA levels by the bDNA assay. The histological features were scored according to the histology activity index. RESULTS: The distribution of HCV genotypes was 1a, 4.6%; 1b, 52.4%; 2a/c, 27%; 3a, 8%; 4, 2%; mixed, 6%. Serum HCV RNA levels were similar for all genotypes. There was no difference in the distribution of HCV genotypes between patients with chronic hepatitis and those with cirrhosis. Patients with genotype 1b and those with type 2a/c showed a similar prevalence of cases of cirrhosis (33% versus 31%, respectively). In addition, in a subgroup of 102 patients with an established date of infection, the progression to cirrhosis occurred with a similar length of time for HCV type 1b and 2a/c (median 16 versus 15 years, respectively). Patients with HCV genotype 2a/c or mixed genotype showed a higher histology activity index than those with type 1b (P< 0.01), whereas there was no difference in the fibrosis score for the different genotypes. Patients with genotype 3a showed a significantly higher prevalence of steatosis compared to those infected with other genotypes. Alanine aminotransferase (ALT) values were higher in patients with HCV type 2a/c, 3a and mixed genotype than those with type 1 (P < 0.002). CONCLUSIONS: The data indicate that there is no association between a particular HCV genotype and the progression to cirrhosis, and that specific genotypes are associated with distinct histopathological and biochemical manifestations although none of them is correlated with an increase of the fibrosis stage.
机译:目的:本研究旨在评估HCV基因型与组织学肝损伤之间的关系。设计:对一组经活检证实为慢性丙型肝炎的患者进行的前瞻性研究。地点:大学医学中心。参与者:连续入组324例患者(男性197例,中位年龄52岁,范围19-68;慢性肝炎224例;肝硬化100例)。方法:通过INNO LiPA测定法测定HCV基因型,通过bDNA测定法测定HCV RNA水平。根据组织学活动指数对组织学特征进行评分。结果:HCV基因型分布为1a,4.6%; 1b,52.4%; 2a / c,27%; 3a,8%; 4,2%;混合,6%。所有基因型的血清HCV RNA水平相似。慢性肝炎和肝硬化患者之间HCV基因型的分布没有差异。基因型1b和2a / c的肝硬化患病率相似(分别为33%和31%)。此外,在102名已确定感染日期的患者亚组中,对于1b和2a / c型HCV,肝硬化的进展时间相近(分别为16岁和15岁)。 HCV基因型2a / c或混合基因型的患者的组织学活性指数高于1b型(P <0.01),而不同基因型的纤维化评分无差异。与感染其他基因型的患者相比,具有基因型3a的患者显示出明显更高的脂肪变性患病率。 HCV 2a / c,3a和混合基因型患者丙氨酸转氨酶(ALT)值高于1型患者(P <0.002)。结论:数据表明特定的HCV基因型与肝硬化的进展之间没有关联,并且特定的基因型与明显的组织病理学和生化表现相关,尽管它们均与纤维化阶段的增加无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号